Yokogawa releases OpreX Quality Management System to accelerate DX in quality assurance processes for the manufacturing of pharmaceuticals and food & beverages

Yokogawa Electric Corporation announces the release today of OpreX™ Quality Management System, a product in the OpreX Operational Risk Management family.

Modest Risks Come With Moving Fast on HF Drugs After Acute Event

CLEVELAND — Adverse events were common with rapid initiation and titration of heart failure medication around a heart failure hospitalization, but they didn’t impact key

October 11, 2023

23andme CEO Anne Wojcicki moves to take company private

After a tumultuous experience on the public markets, 23andMe CEO Anne Wojcicki is moving to take the company private. Wojcicki disclosed her plans in a

April 18, 2024

RG-6540 by F. Hoffmann-La Roche for Follicular Lymphoma: Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

December 31, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.